Autologous CD19 CAR-T
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. (NCT06231368) | Institute of Hematology & Blood Diseases Hospital, China | 2024-02-04 |
Track Autologous CD19 CAR-T automatically
Every clearance here is in the API, with alerts when new ones post.